Cargando…
Anti-colorectal cancer effects of anti-p21Ras scFv delivered by the recombinant adenovirus KGHV500 and cytokine-induced killer cells
BACKGROUND: Colorectal cancer (CRC) is the most common type of gastrointestinal cancer. CRC gene therapy mediated by adenovirus holds great promise for the treatment of malignancies. However, intravenous delivery of adenovirus exhibits limited anti-tumor activity in vivo when used alone. METHODS: In...
Autores principales: | Liu, Fang-Rui, Bai, Shuang, Feng, Qiang, Pan, Xin-Yan, Song, Shu-Ling, Fang, Hong, Cui, Jing, Yang, Ju-Lun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6233365/ https://www.ncbi.nlm.nih.gov/pubmed/30419845 http://dx.doi.org/10.1186/s12885-018-4989-y |
Ejemplares similares
-
Recombinant Adenovirus KGHV500 and CIK Cells Codeliver Anti-p21-Ras scFv for the Treatment of Gastric Cancer with Wild-Type Ras Overexpression
por: Wang, Mingjuan, et al.
Publicado: (2018) -
Cytokine-induced killer cells carrying recombinant oncolytic adenovirus expressing p21Ras scFv inhibited liver cancer
por: Dai, Fang, et al.
Publicado: (2021) -
BR2 cell penetrating peptide effectively delivers anti-p21Ras scFv to tumor cells with ganglioside expression for therapy of ras-driven tumor
por: Yu, Ting, et al.
Publicado: (2022) -
Inhibition of human lung cancer cells by anti-p21Ras scFv mediated by the activatable cell-penetrating peptide
por: Du, Yu, et al.
Publicado: (2021) -
A novel anti-p21Ras scFv antibody reacting specifically with human tumour cell lines and primary tumour tissues
por: Yang, Ju-Lun, et al.
Publicado: (2016)